ResMed Inc. Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount
ResMed Inc. (RMD) reported Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount of $4.89 million for the 12-month period ending 2023-06-30, per its 10-K filed 2023-08-11.
Discontinued › Notes › Investments
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount · last filed 2023-08-11
- ResMed Inc. equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2023 was $4.89M, a 52.45% increase from fiscal 2022.
- ResMed Inc. equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2022 was $3.21M.
| Period end | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 12 month |
|---|---|
| 2023-06-30 | $4.89M 10-K · filed 2023-08-11 |
| 2022-06-30 | $3.21M 10-K · filed 2023-08-11 |